306 related articles for article (PubMed ID: 24044277)
1. [From Gurdon to Yamanaka--a brief history of cell reprogramming].
Kubiak JZ; Ciemerych MA
Postepy Biochem; 2013; 59(2):124-30. PubMed ID: 24044277
[TBL] [Abstract][Full Text] [Related]
2. Reprogramming rewarded: the 2012 Nobel Prize for Physiology or Medicine awarded to John Gurdon and Shinya Yamanaka.
Johnson MH; Cohen J
Reprod Biomed Online; 2012 Dec; 25(6):549-50. PubMed ID: 23211094
[No Abstract] [Full Text] [Related]
3. Profile of John Gurdon and Shinya Yamanaka, 2012 Nobel laureates in medicine or physiology.
Colman A
Proc Natl Acad Sci U S A; 2013 Apr; 110(15):5740-1. PubMed ID: 23538305
[No Abstract] [Full Text] [Related]
4. From stealing fire to cellular reprogramming: a scientific history leading to the 2012 Nobel Prize.
Lensch MW; Mummery CL
Stem Cell Reports; 2013 Jun; 1(1):5-17. PubMed ID: 24052937
[TBL] [Abstract][Full Text] [Related]
5. Cellular alchemy and the golden age of reprogramming.
Daley GQ
Cell; 2012 Dec; 151(6):1151-4. PubMed ID: 23217698
[TBL] [Abstract][Full Text] [Related]
6. An interview with John Gurdon.
Maartens A
Development; 2017 May; 144(9):1581-1583. PubMed ID: 28465332
[TBL] [Abstract][Full Text] [Related]
7. Roles of small molecules in somatic cell reprogramming.
Su JB; Pei DQ; Qin BM
Acta Pharmacol Sin; 2013 Jun; 34(6):719-24. PubMed ID: 23728722
[TBL] [Abstract][Full Text] [Related]
8. Bone transplantation and tissue engineering, part IV. Mesenchymal stem cells: history in orthopedic surgery from Cohnheim and Goujon to the Nobel Prize of Yamanaka.
Hernigou P
Int Orthop; 2015 Apr; 39(4):807-17. PubMed ID: 25750132
[TBL] [Abstract][Full Text] [Related]
9. Chromatin roadblocks to reprogramming 50 years on.
Skene PJ; Henikoff S
BMC Biol; 2012 Oct; 10():83. PubMed ID: 23107587
[TBL] [Abstract][Full Text] [Related]
10. Timeline: iPSCs--The First Decade.
Chari S; Mao S
Cell Stem Cell; 2016 Feb; 18(2):294. PubMed ID: 26849306
[TBL] [Abstract][Full Text] [Related]
11. Advances in cell lineage reprogramming.
Zhou J; Yue W; Pei X
Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
[TBL] [Abstract][Full Text] [Related]
12. [IPS an ethical paradigm for biomedical research].
Gámez Escalona JA
Cuad Bioet; 2013; 24(82):419-42. PubMed ID: 24483317
[TBL] [Abstract][Full Text] [Related]
13. The egg and the nucleus: a battle for supremacy.
Gurdon JB
Development; 2013 Jun; 140(12):2449-56. PubMed ID: 23715537
[TBL] [Abstract][Full Text] [Related]
14. Sir John Gurdon: father of nuclear reprogramming.
Blau HM
Differentiation; 2014 Jul; 88(1):10-12. PubMed ID: 24954777
[TBL] [Abstract][Full Text] [Related]
15. [Two 2012 Nobel prizes in medicine and physiology].
Nau JY
Rev Med Suisse; 2012 Oct; 8(358):1986-7. PubMed ID: 23198653
[No Abstract] [Full Text] [Related]
16. Yoshiki Sasai 1962–2014.
De Robertis EM
Dev Cell; 2014 Sep; 30(5):509-11. PubMed ID: 25340213
[No Abstract] [Full Text] [Related]
17. Reprogramming to pluripotency: from frogs to stem cells.
Rossant J
Cell; 2009 Sep; 138(6):1047-50. PubMed ID: 19766555
[TBL] [Abstract][Full Text] [Related]
18. [Current status and perspective on regenerative medicine for spinal cord injury using iPS cell].
Nakamura M; Toyama Y; Okano H
Rinsho Shinkeigaku; 2013; 53(11):1013-5. PubMed ID: 24291863
[TBL] [Abstract][Full Text] [Related]
19. Perspective for special Gurdon issue for differentiation: can cell fusion inform nuclear reprogramming?
Burns D; Blau HM
Differentiation; 2014 Jul; 88(1):27-28. PubMed ID: 25150886
[TBL] [Abstract][Full Text] [Related]
20. iPS Cells 10 Years Later.
Cell; 2016 Sep; 166(6):1356-1359. PubMed ID: 27610558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
